231 related articles for article (PubMed ID: 19427822)
21. Immunodulation with tacrolimus (FK506): results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease.
de Oca J; Vilar L; Castellote J; Sánchez Santos R; Parés D; Biondo S; Osorio A; del Rio C; Jaurrieta E; Martí Ragué J
Rev Esp Enferm Dig; 2003 Jul; 95(7):465-70, 459-64. PubMed ID: 14515846
[TBL] [Abstract][Full Text] [Related]
22. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
23. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice.
Saibeni S; Virgilio T; D'Incà R; Spina L; Bortoli A; Paccagnella M; Peli M; Sablich R; Meucci G; Colombo E; Benedetti G; Girelli CM; Casella G; Grasso G; de Franchis R; Vecchi M
Dig Liver Dis; 2008 Oct; 40(10):814-20. PubMed ID: 18479986
[TBL] [Abstract][Full Text] [Related]
24. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
Thaçi D; Reitamo S; Gonzalez Ensenat MA; Moss C; Boccaletti V; Cainelli T; van der Valk P; Buckova H; Sebastian M; Schuttelaar ML; Ruzicka T;
Br J Dermatol; 2008 Dec; 159(6):1348-56. PubMed ID: 18782319
[TBL] [Abstract][Full Text] [Related]
25. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience.
Benson A; Barrett T; Sparberg M; Buchman AL
Inflamm Bowel Dis; 2008 Jan; 14(1):7-12. PubMed ID: 17879277
[TBL] [Abstract][Full Text] [Related]
27. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis.
Stumpf T; Luqmani N; Sumich P; Cook S; Tole D
Cornea; 2006 Dec; 25(10):1147-9. PubMed ID: 17172887
[TBL] [Abstract][Full Text] [Related]
28. Rectal tacrolimus in the treatment of resistant ulcerative proctitis.
Lawrance IC; Copeland TS
Aliment Pharmacol Ther; 2008 Nov; 28(10):1214-20. PubMed ID: 18761706
[TBL] [Abstract][Full Text] [Related]
29. [Cyclosporine in inflammatory bowel disease].
Colomina Avilés J; Pascual Pérez R; Ortuño Cortés J; García García A; Del Pino Cuadrado J
An Med Interna; 1998 Apr; 15(4):214-8. PubMed ID: 9608068
[TBL] [Abstract][Full Text] [Related]
30. Response to induction therapy in a pediatric population of inflammatory bowel disease.
Motamed F; Famouri F; Najafi M; Moazzami K; Farahmand F; Khodadad A; Fallahi GH; Khatami GR; Rezaei N
Z Gastroenterol; 2010 Jul; 48(7):748-52. PubMed ID: 20607631
[TBL] [Abstract][Full Text] [Related]
31. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
Mossop H; Davies P; Murphy MS
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
[TBL] [Abstract][Full Text] [Related]
32. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease.
Baumgart DC; Wiedenmann B; Dignass AU
Aliment Pharmacol Ther; 2003 May; 17(10):1273-81. PubMed ID: 12755840
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
[TBL] [Abstract][Full Text] [Related]
34. Infliximab for ulcerative colitis in children and adolescents.
McGinnis JK; Murray KF
J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529
[TBL] [Abstract][Full Text] [Related]
35. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
36. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
[TBL] [Abstract][Full Text] [Related]
37. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
38. Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient.
Hernández G; Jiménez C; Arriba L; Moreno E; Lucas M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov; 92(5):526-31. PubMed ID: 11709689
[TBL] [Abstract][Full Text] [Related]
39. Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.
Kawakami K; Inoue T; Murano M; Narabayashi K; Nouda S; Ishida K; Abe Y; Nogami K; Hida N; Yamagami H; Watanabe K; Umegaki E; Nakamura S; Arakawa T; Higuchi K
World J Gastroenterol; 2015 Feb; 21(6):1880-6. PubMed ID: 25684955
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
